Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending September 13, 2020 Social distancing impacts other infectious diseases, MIS-C cardiac evaluation requires more than EF, More must reads Must reads for theWeek ending August 30, 2020 EMPEROR-Reduced: Empagliflozin's HFrEF benefit solidifies class effects, SARS-CoV-2 appears unlikely to pass through breast milk, Anorexia may stunt growth in teenage girls, Nine antihypertensive drugs associated with reduced risk of depression, More must readsMust reads for theWeek ending August 30, 2020 EMPEROR-Reduced: Empagliflozin's HFrEF benefit solidifies class effects, SARS-CoV-2 appears unlikely to pass through breast milk, Anorexia may stunt growth in teenage girls, Nine antihypertensive drugs associated with reduced risk of depression, More must readsMust reads for theWeek ending August 23, 2020 SGLT2 inhibitors with metformin look safe for bone, Diabetes plus weight loss equals increased risk of pancreatic cancer, Osteoporosis tied to increased periodontitis risk, Alendronate vs raloxifene for preventing osteoporotic fractures, Baseline vitamin D status may not influence the efficacy of denosumab, More must readsMust reads for theWeek ending August 16, 2020 Determining cause of skin lesions in COVID-19 patients remains challenging, RA patients show decreased risk for new-onset type 2 diabetes, Since COVID-19 onset, admissions for MI are down, mortality rates are up, Hypertension often goes undertreated in patients with a history of stroke, Health disparities training falls short for internal medicine residents, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 last »
